Canadian clinical trial tests ‘old’ plasma therapy for COVID-19
- The Globe and Mail, CTV News, Global News and CBC The Current spoke to Donald Arnold (Medicine/Hematology) about a national clinical trial he is leading to test a treatment involving taking blood plasma from people who have recovered from COVID-19 infection and giving it to patients who are hospitalized with the same disease. There was pick up by other media organizations.
New moms still finding peer support during COVID-19 pandemic
- Ryan Van Lieshout (Psychiatry and Behavioural Neurosciences) spoke to the Hamilton Spectator about the loss of social support during physical distancing for women who are coping with depression and anxiety. The Chronicle Herald published an opinion piece by Van Lieshout on the topic at The Conversation Canada.
Experts cautiously optimistic B.C. has turned the corner
- Dawn Bowdish (Pathology and Molecular Medicine/IIDR) spoke to Global News about the slowing of the number of cases of COVID-19 in B.C. and why there’s hope for Ontario. Bowdish also contributed to a conversation at The Paper Gown about boosting immunity.
Professionals share their stories
- Cathy Risdon (Family Medicine) spoke to the Globe and Mail about the difficult conversations that everyone – including health care workers – need to have with family.
Surgical masks; and safety of residents in long-term care
- Mark Loeb (Pathology and Molecular Medicine/IIDR) was quoted in a Hamilton Spectator article on whether medical masks are effective during the pandemic. There was international coverage of his current research on masks at Outlook India, Free Press Journal, Press Trust of India, Indo-Asian News Service, and others. Additionally, the Hamilton Spectator interviewed Loeb about the safety of residents in long-term care, and that article was picked up by several local newspapers.
Ticketing the homeless
- Claire Bodkin (Family Medicine) spoke to CHML radio about caring for the homeless during the pandemic. (Starting at 16:33)
In appreciation of front line workers
- Jobin Varughese and PGY1 resident Jasneet Dhaliwal (Family Medicine) were guests on the new CBC Show, What're You At. The episode checked in with front line workers to see how they are doing.
COVID-19 could lead to neurological problems in some patients
- Boris Sakic (Psychiatry and Behavioural Neurosciences) spoke to the Globe and Mail about how during a “cytokine storm,” or a severe immune reaction in certain individuals, the blood-brain barrier can become permeable.
Second Act: Former CEO of RadioShack now an ER doctor
- McMaster medicine grad Brian Levy spoke to the National Post about his unusual career path.
A cautious approach to COVID-19 drugs
- Salim Yusuf (Population Health Research Unit) spoke to the National Post about the urge to try unproven treatments for COVID-19, and the consequences.
Cannabis: A potential treatment for MRSA
- Eric Brown (Biochemistry and Biomedical Sciences/IIDR) spoke to the Cannabis Health Insider about why MRSA remains a problem, and suggested it may not be too far-fetched to envision a day when CBG can be used as a treatment.
- Jonathan Dushoff (Biology/IIDR) spoke to the Globe and Mail, Hamilton Spectator and CTV News about modelling projections and what’s being counted.
Priorities in an overwhelming pandemic
- Niagara Now published an opinion piece by William Brown (Medicine) about containment measures and priorities.
- PJ Devereaux (Population Health Research Institute) talked with CHCH TV about a study he is leading looking at optimal timing to treat hip fractures.
Fad diets keep fat off only for one year
- Several media outlets posted articles about research by Gordon Guyatt (Health Research Methods, Evidence and Impact) that shows you can expect the same initial weight loss on any diets -- so which one you choose is really a matter of personal preference. Coverage included, The Indian Express, Drug.com, US News and World Report, HealthDay Consumer, London Daily Mail, New Scientist, MarketWatch, The Mercury, Cape Times, Pretoria News, Irish and Scottish Daily Mail, The Sun and more.